# Clinical Pharmacology Study of MT-3534 in Healthy Adult Male Volunteers

> **NCT06482346** · PHASE1 · COMPLETED · sponsor: **Tanabe Pharma Corporation** · enrollment: 56 (actual)

## Conditions studied

- Healthy Adult Male Volunteers

## Interventions

- **BIOLOGICAL:** MT-3534
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT06482346
- **Lead sponsor:** Tanabe Pharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-09
- **Primary completion:** 2025-07-09
- **Final completion:** 2025-07-09
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2025-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06482346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06482346, "Clinical Pharmacology Study of MT-3534 in Healthy Adult Male Volunteers". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06482346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*